The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.
During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.
This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."
The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.
More top news
Temperatures will tumble under clear skies tonight with a widespread frost developing.
Police found more than 20 cannabis plants, a small amount of cocaine and a prohibited stun-gun at the home of Richard Williams.
Finance Secretary Mark Drakeford and his Scottish and Northern Irish counterparts demand no further public spending cuts in the UK Budget.